Kennedy Thomas Ronan 4
4 · cbdMD, Inc. · Filed May 8, 2025
Insider Transaction Report
Form 4
cbdMD, Inc.YCBD
Kennedy Thomas Ronan
DirectorCEO and CFO
Transactions
- Conversion
8% Series A Cumulative Convertible Preferred Stock
2025-05-06−41,765→ 0 total→ Common Stock (67,869 underlying) - Conversion
Common Stock
2025-05-06+67,869→ 74,501 total
Footnotes (3)
- [F1]The 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") automatically converted into shares of common stock without any action on the part of the Reporting Person. The automatic conversion converts each share of the Preferred Stock into thirteen shares of the Company's common stock on May 6, 2025 at 4:01 p.m. Eastern Time.
- [F2]The price gives effect to the one-for-8 reverse stock split of the Company's issued and outstanding shares of common stock, effective May 6, 2025 at 4:02 p.m. Eastern Time.
- [F3]Open market purchases.